RESEARCH GRANT AWARDS
AWARDS LIST.
Totals by Year
2020 - $630,000
2019 - $690,000
2018 - $750,000
2017 - $747,772
2016 - $720,000
2015 - $840,000
2014 - $810,000
2013 - $808,500
2012 - $720,000
2011 - $599,780
2010 - $438,000
2009 - $435,000
2008 - $619,993
2007 - $232,600
2006 - $384,551
Ryan Marker, PhD
​
2020
$ 30,000
Feasibility and effectiveness of an Innovative exercise program to reduce fatigue in rural cancer survivors
Breelyn Wilky, MD & Eduardo Davila, PhD
​
2020
$ 60,000
Toxicity and Biodistribution of CD*:MyD88 Engineered Autologous T Cells In Mouse Models of Melanoma and Fibrosarcoma
Zachary Graff, MD
​
2020
$ 30,000
Development of Bispecific CAR T-cells for the Prevention of Lineage Switch in KMT2A-rearranged Leukemia
Senthilnath Lakshmana Chetty, PhD
​
2020
$ 30,000
Combining radiation and Immunotherapy to target diffuse midline gliomas with the H3K27M mutation
Christine Towers, PhD
​
2020
$ 30,000
Identifying novel regulators of mitochondrial turn over
Swati G. Patel, MD, MS
​
2020
$ 30,000
Identification of Hereditary Cancer Syndromes through Advanced Polyps
Rebecca Schweppe, PhD
​
2020
$ 30,000
The role of Nuclear FAK in Thyroid Cancer
Sujatha Venkataraman PhD & Adam Green, MD & Mark Kohler, MD, PhD
​
2020
$ 60,000
Engineering Logic-Gated DC99 CAR to selectively target H3K27M-DIPG tumor cells and to protect normal cells
Matthew Tallaferro, PhD
​
2020
$ 30,000
Control of cell division through centrosomal RNA localization
Raphael Nemenoff, PhD & Erin Schenk, MD, PhD
​
2020
$ 60,000
The Tumor Microenvironment as a Critical Regulator of Targeted Therapy in ALK Positive Lung Cancer
Paula Jedlicka, MD, PhD
​
2020
$ 30,000
Understanding and targeting highly metastatic EWS/FLi1-low cells in Ewing Sarcoma
Mayumi Fujita, MD, PhD & Charles A. Dinarello, MD
​
2020
$ 60,000
The role of alpha-1 antitrypsin in cancer immunotherapy
Molishree Joshi, PhD
​
2020
$ 30,000
A novel CRISPR-mediated tumor targeting strategy for Liiposarcoma
Diana M. Cittelly, PhD
​
2020
$ 30,000
Function of Ephrin B Signaling in Breast cancer brain metastasis
Maureen Lynch, Phd & Philip Owens, PhD
​
2020
$ 60,000
The role of exercise in breast cancer bone metastasis
Matthew Sikora, PhD
​
2019
$ 30,000
Defining MDC1 as a central regulator of estrogen receptor and DNA repair in lobular carcinoma
Isabel Schlaepfer, PhD
​
2019
$ 30,000
Role of fat oxidation via CPT1A in immunological response to prostate cancer
Rajeev Vibhakar, MD, PhD, MPH
​
2019
$ 30,000
Role of CDK7 in medulloblastoma
John Tentler, PhD
​
2019
$ 30,000
Cancer Research Summer Fellowship Program
Jay Hesselberth, PhD
​
2019
$ 30,000
Single-cell methods to measure functional heterogeneity
Mayumi Fujita, MD, PhD & Donald Backos, PhD
​
2019
$ 60,000
Somatic mutations in inflammasome genes in melanoma
Sujatha Venkataraman, PhD and Mark Kohler, MD, PhD
​
2019
$ 60,000
CD99 targeting CAR T cells as a novel therapy for H3K27M mutant DIPG
Zachary Levi Watson, PhD
​
2019
$ 30,000
Targeting histone acetylation in PARP inhibitor-resistant ovarian cancer
Cem Altunbas, PhD
​
2019
$ 30,000
High-fidelity volumetric imaging for quantitative treatment monitoring and modifications in radiation therapy
Neelanjan Mukherjee, PhD & Daniel Sherbenou, MD, PhD
​
2019
$ 60,000
Exploiting mRNA translation inhibition for the treatment of relapsed/refractory multiple myeloma
Carol Sartorius, PhD
​
2019
$ 30,000
PR-RAR downregulation of protein synthesis and cell growth in breast cancer
Heather Brechbuhl, PhD
​
2019
$ 30,000
Defining reversible tumor traits in the obese microenvironment
Shi-Long Lu, MD, PhD and Daniel Frank, PhD
​
2019
$ 60,000
Mechanism of oral microbiota in head and neck cancer pathogenesis and application for targeted therapy
Yiqun Shellman, PhD & Martin McCarter, MD
​
2019
$ 60,000
Targeting anti-apoptotic pathways to improve immunotherapies for melanoma
Paul Norman, PhD
​
2019
$ 30,000
Natural Killer cells can protect from developing leukemia
Stephen Keysar, PhD
​
2019
$ 30,000
Targeting of stemness factors and fusion proteins in salivary gland cancers through inhibition of translation elongation
Neil Box, PhD
​
2019
$ 30,000
Regulation of p53 in tanning
Adam Mueller, MD, PhD
​
2019
$ 30,000
Investigating crosstalk between ADAM10 and EphrinB2/EPHB4 in mediating radiation induced fibrosis, invasion and metastasis in pancreatic cancer
Jill Slansky PhD
​
2018
$ 30,000
Functional activation of low-affinity T cells in the tumor
David Thomas, PhD and Mark Borden, PhD
​
2018
$ 30,000
X-Ray Acoustic Computed Tomography Guided Adaptive Radiotherapy
Zhangguo Chen, PhD
​
2018
$ 30,000
Elucidating mechanisms by which a newly developed HDAC inhibitor sensitizes B cell lymphomas to PD-1 therapy
Courtney Jones, PhD
​
2018
$ 30,000
Targeting relapse leukemia stem cells through inhibition of NAD synthesis
Linda Van Dyk, PhD
​
2018
$ 30,000
Role of CDK4 and CDK6 in gammaherpesvirus oncogenesis
Mair E.A. Churchill, PhD
​
2018
$ 30,000
Inhibition of Chromatin Assembly Factor 1 B to Reverse Leukemogenesis
Nicholas Forman, MD
​
2018
$ 30,000
Characterization of heterogeneous tumor subpopulations in childhood ependymoma
John Tentler, PhD
​
2018
$ 30,000
Cancer Research Summer Fellowship Program
Nathan Dahl, MD
​
2018
$ 30,000
Oncogenic Role of the Super Elongation Complex in H3K27M-mutant Diffuse Midline Glioma
Jennifer DeLuca, PhD
​
2018
$ 30,000
Targeting Kinetochore Dysfunction in Cancer Cells
Martin McCarter, MD
​
2018
$ 30,000
Improving immune checkpoint inhibitor efficacy by targeting myeloid-derived suppressor cell function
Benjamin Bitler, PhD
​
2018
$ 30,000
Investigating the mechanisms of EHMT1/2-dependent PARP inhibitor resistance
Adwitiya Kar, PhD and Margaret Wierman, MD
​
2018
$ 30,000
Targeting Maternal Embryonic Leucine Zipper Kinase (MELK) in the first pre-clinical models of Adrenocortical Carcinoma
Christopher Lieu, MD and Todd Pitts, MD
​
2018
$ 60,000
Investigating the role of MEK and non-canonical Wnt inhibition in altering the immune microenvironment in metastatic colorectal cancer
Jessica Lake, MD, MPH
​
2018
$ 30,000
IPS-derived, CAR-expressing Natural Killer Cells Targeting EGFR on Pediatric Sarcomas
David Ryan Ormond MD
​
2018
$ 30,000
Diffusion tensor image tractography in surgical resection of glioblastoma resection and surgical safety
Katja Kiseljak-Vassiliades, DO and Kimberly Jordan, PhD
​
2018
$ 60,000
Potentiating anti-PD1 Immunotherapy with Mitotane in Adrenocortical Carcinoma
Jennifer Hintzsche, PhD
​
2018
$ 30,000
Patient-centric Multi-Omics Approach to Identifying Actionable Therapeutics in Cancer
Scott Cramer, PhD and James Costello, PhD
​
2018
$ 60,000
Targeting the Achilles heel of prostate cancer with loss of CHD1 and MAP3K7
Maria Jose Contreras, PhD
​
2018
$ 30,000
Mechanisms of TDM1/radiation-induced toxicity in brain metastases
Raul M. Torres, PhD
​
2018
$ 30,000
Suppression of human CD8 T cell antigen receptor signaling and cytotoxic activity by lysophosphatidic acid
Rebecca Schweppe, PhD
​
2018
$ 30,000
Cooperative Src and MAP Kinase Signaling in Thyroid Cancer
Eric Clambey, PhD
​
2017
30,000
High-dimensional analysis of effector T cell mechanisms in lung cancer
Jung-Jae Lee, PhD
​
2017
29,835
Storable, Thermally Activated, Self-Illuminating Nanoparticles Optical Imaging of Cancer
David Bentley, PhD
​
2017
30,000
Deregulation of mRNA 3′ end formation in breast cancer
Jing H. Wang, MD, PhD
​
2017
30,000
Elucidate novel mechanisms of chemotherapy agent-treated lymphomas to activate immune responses
Britta Jacobsen, PhD
​
2017
30,000
Examining the role of c-Kit in metastasis of Invasive Lobular Breast Cancer
Traci R. Lyons, PhD and Beth Taburini, PhD
​
2017
60,000
Evaluating the role of pro-lymphangiogenic factor Sem7a in dampening anti-tumor immunity
Matthew J. Sikora, PhD
​
2017
30,000
Exploiting apoptotic vulnerability in anti-estrogen response and resistance in invasive lobular carcinoma
Kasey Couts, PhD
​
2017
30,000
Improving targeted therapy in melanomas with BRAF fusions
James DeGregori, PhD
​
2017
30,000
Understanding how smoking alters selection for common oncogenic mutations in the genesis of lung cancer
Sana Karam, MD, PhD
​
2017
30,000
Enhancing the Effects of Immune Checkpoint Blockade with Radiation Therapy in Head and Neck Cancer
Rebecca Schweppe, PhD
​
2017
30,000
Targeting FAK and Src in Thyroid Cancer
John Tentler, PhD
​
2017
30,000
Cancer Research Summer Fellowship Program
Daniel V. LaBarbera, PhD and Wells A. Messersmith, MD
​
2017
60,000
Patient Derived Tumor Organoids for Personalized and Targeted Colorectal Cancer Therapeutics
Todd Hankinson, MD, MBA
​
2017
27,976
Comparison of Adult Adamantinomatous Craniopharyngioma Gene Expression with Known Pediatric Gene Expression
Changwei Liu, PhD
​
2017
30,000
Validating USP35 as an anticancer drug target
Hyunmin Kim, PhD
​
2017
30,000
Systematic Alternative Splicing Analysis for Trancriptomic Misregulation in Cancer
Darinee Tippimanchai, PhD
​
2017
30,000
Targeting IL17 in Kras mutant lung cancer
Jenna Sopfe, MD
​
2017
29,961
Evaluation of Malgylcemia via Continuous Glucose monitoring in the Pediatric Hematopoietic Stem Cell Transplant Population
Dan Theodorescu, MD, PhD
​
2017
30,000
Whole genome knockout screening to identify novel TERT regulators with prognostic relevance in bladder cancer patients
James Costello, PhD
​
2017
30,000
Measuring chromosome-conformation abnormalities within a single cancer cell